|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.52% | -0.28% | -0.50% | +11.45% | 47.74B | ||
| -1.84% | +0.75% | +395.63% | +618.28% | 39.98B | ||
| +0.58% | +2.92% | +11.37% | +45.69% | 36.23B | ||
| +12.67% | +19.39% | +21.72% | +6.44% | 35.59B | ||
| -0.73% | +2.78% | +4.65% | +41.16% | 27.91B | ||
| -1.69% | -2.28% | - | - | 16.71B | ||
| -1.34% | +10.17% | +29.28% | +129.87% | 16.45B | ||
| +2.39% | -1.64% | +4.74% | +9.95% | 13.21B | ||
| +7.15% | +8.81% | -4.41% | -28.10% | 12.93B | ||
| Average | +2.03% | +2.78% | +57.81% | +104.34% | 27.42B | |
| Weighted average by Cap. | +1.97% | +2.95% | +76.49% | +131.30% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















